Evidence map›Paper›PMID 31948402›Full record

ArticleBMC infectious diseases2020

Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's hospital.

Jinrong Liu, Ruxuan He, Runhui Wu, Bei Wang, Hui Xu, Yue Zhang, Huimin Li, Shunying Zhao

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Independent risk factors for refractory mycoplasma pneumoniae pneumonia in children: a multivariate analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  8. East Asia as a sentinel: risk-stratified corticosteroid therapy for paediatric macrolide-resistantEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Exploring Clinical Characteristics and Risk Factors ofJournal of inflammation research · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jinrong LiuDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China.
Ruxuan HeDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China.
Runhui WuHematology Oncology Center, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, Beijing, 100045, China.
Bei WangDepartment of Radiology, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, Beijing, 100045, China.
Hui XuDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China.
Yue ZhangDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China.
Huimin LiDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China.
Shunying ZhaoDepartment of Respiratory Medicine, Beijing Children's Hospital, National Centre for Children's Health, Capital Medical University, NO.56, Nanlishi Road, Xicheng District, Beijing, 100045, People's Republic of China. zhaoshunying2001@126.com.
Beijing Children’s Hospital · CNCapital Medical University · CNPeking University First Hospital · CN

Funding

Beijing Municipal and Commission Health and Family Planning 2015-3-076
6 · The paper itself

Abstract

backgroundWith the increase of awareness of mycoplasma pneumoniae pneumonia (MPP), we found thrombosis in severe MPP (SMPP) was not rare. The aim of the study was to investigate the clinical characteristics, treatment, and long-term prognosis of MPP-associated thrombosis.

methodsWe retrospectively reviewed the medical records of 43 children with MPP-associated thrombosis between January 2013 and June 2019 at Beijing Children's Hospital. The results of blood coagulation studies, autoimmune antibody, thrombophilia screening, contrast-enhanced lung computed tomography, echocardiography, and blood vessel ultrasonography were analyzed, as were treatment outcomes.

resultsForty-two patients were diagnosed with SMPP. D-dimer was higher than 5.0 mg/L in 58.1% (25/43) of patients. The mean D-dimer level was 11.1 ± 12.4 mg/L. Anticardiolipin-IgM was positive in 60.0% of patients, β2-glycoprotein-IgM in 64.0%, and lupus anticoagulant in 42.1%. Chest imaging revealed pulmonary consolidation with lobe distribution in all patients (2/3-1 lobe in 10 patients, > 1 lobe in 29 patients). In our experience, thrombosis can occur in a vessel of any part of the body, and it can be initially detected as late as 31 days after disease onset. Thrombosis in the brain and abdomen can occur early, at 5 days after disease onset. Pulmonary vessels were the most commonly involved sites in the current study, and accordingly chest pain was the most common symptom (32.6%), followed by neurological symptoms (14.0%) and abdominal pain (9.3%). Thirty-five percent of patients were asymptomatic with regard to thrombosis. All patients underwent anticoagulant therapy, and thrombus absorption took > 3 months in most patients. All patients were followed until October 2019, at which time 41 were asymptomatic and 2 had mild recurrent cough.

conclusionsSMPP with pulmonary consolidation (> 2/3 lobe) was the most strongly associated risk factor for thrombosis. Thrombosis-associated symptoms may be subtle, even absent. Elevated D-dimer, specifically > 11.1 mg/L (even > 5.0 mg/L), would assist in the early diagnosis of thrombosis. The long-term prognosis of thrombosis was good after timely administration of anticoagulant therapy.

Indexed as

Antibodies, AnticardiolipinAnticoagulantsBeijingChest PainChildChild, PreschoolFemaleFibrin Fibrinogen Degradation ProductsHospitals, PediatricHumansMaleMycoplasma pneumoniaePneumonia, MycoplasmaPrognosisRetrospective StudiesThrombosisAntibodies, AnticardiolipinAnticoagulantsFibrin Fibrinogen Degradation Productsfibrin fragment DChildrenMycoplasma pneumoniaePneumoniaSevereThrombosis

Identifiers

PMID31948402
PMCPMC6966865
OpenAlexW3003817454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.